HomepageLGND • NASDAQ
add
Ligand Pharmaceuticals
Vorige slotkoers
$Â 106,28
Dag-range
$Â 102,79 - $Â 106,02
Jaar-range
$Â 67,53 - $Â 129,90
Beurswaarde
1,98Â mld. USD
Gem. volume
121,41K
Koers/winst
43,24
Dividendrendement
-
Primaire beurs
NASDAQ
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (USD) | sep 2024info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 51,81Â mln. | 57,64% |
Bedrijfskosten | 32,73Â mln. | 42,98% |
Netto inkomsten | -7,17Â mln. | 30,19% |
Netto winstmarge | -13,84 | 55,73% |
Winst per aandeel | 1,84 | 80,39% |
EBITDA | 19,95Â mln. | 92,15% |
Effectief belastingtarief | -13,14% | — |
Balans
Totale activa
Totale passiva
| (USD) | sep 2024info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 219,64Â mln. | 15,30% |
Totale activa | 954,87Â mln. | 24,13% |
Totale passiva | 113,69Â mln. | 12,20% |
Totaal aandelenvermogen | 841,18 mln. | — |
Uitstaande aandelen | 18,90 mln. | — |
Koers-boekwaardeverhouding | 2,37 | — |
Rendement op activa | 3,01% | — |
Rendement op kapitaal | 3,36% | — |
Kasstroom
Nettomutatie in liquide middelen
| (USD) | sep 2024info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | -7,17Â mln. | 30,19% |
Operationele kasstroom | 36,53Â mln. | 377,77% |
Kasstroom uit beleggingen | -46,51Â mln. | -138,46% |
Kasstroom uit financiering | 55,08Â mln. | 1.584,40% |
Nettomutatie in liquide middelen | 45,48Â mln. | 629,64% |
Vrije kasstroom | 32,53Â mln. | 1.377,31% |
Over
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company located in San Diego, California. Founded in 1987 as Progenix Inc., the company went public in 1992. Initially focused on developing its own drugs, a period of turbulence in the early 2000s culminated in its CEO being ejected by the shareholders and provoked a change in focus to the acquisition of existing drugs and forming partnerships to develop them further.
The company has been the subject of multiple regulatory investigations, negative shorts-seller reports and class action lawsuits amid allegations of securities fraud.
In 2018 its CEO was listed among the top five highest paid CEOs in San Diego. Wikipedia
Opgericht
sep 1987
Website
Werknemers
58
